TUCSON Study: Tackling Underlying Causes Of Sleep Related Nocturia Nocturia

计划入组 200 人 · 首次发布于 2022 年 6 月 3 日

Moxibustion for Nocturia

计划入组 100 人 · 首次发布于 2026 年 5 月 20 日

Study Investigating the Impact Burden of Nocturia Using the Nocturia Impact Diary

计划入组 56 人 · 首次发布于 2012 年 3 月 13 日

Desmopressin(Ddavp, Nocdurna, Octostim)

C₄₆H₆₄N₁₄O₁₂S₂ · Rx

Flavoxate

C₂₄H₂₅NO₄

C3b recognition inhibitors (oral, paroxysmal nocturnal hemoglobinuria)

NOCTRIX HEALTH, INC.

United States

Daridorexant Shows Promising Results in Improving Night-to-Day Transition for Insomnia Patients

Vibegron Shows Sustained Long-Term Safety and Efficacy for Men with OAB and BPH

Urovant Sciences Launches GEMTESA® (vibegron) for Overactive Bladder Treatment in the U.S.